Issues related to domestic pharmaceutical manufacturing; issues related to supply chain resilience.
2026 · 2nd Quarter (Apr 1 - June 30)
PAR HEALTH USA, LLC
Filed by FOLEY & LARDNER LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 19, 2026
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- FOLEY & LARDNER LLP
- Client
- PAR HEALTH USA, LLC
- Filing UUID
- baaddc07-9e0d-4350-8b82-bf7697043481
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical tariffs
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.